Purchase Order 75N92024P00224
Award Date
7/11/24
Potential Completion Date
7/10/25
Potential Value
$17K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Repeat Diagnostics Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health National Heart, Lung and Blood Institute awarded a firm fixed price purchase order valued at $21,000 to Repeat Diagnostics Inc. of Ottawa, Canada. Under this contract, Repeat Diagnostics will provide telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assay for samples from the Young Lab Members at NIH NHLBI. The work will involve testing patient samples from the lab's clinic to repeat their telomere length...
This federal contract award, valued at $12,500.00, was granted by the National Heart, Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assays to support NHLBI's "YOUNG LAB" research initiative. The goal of this research...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $11,250 firm fixed price purchase order to Repeat Diagnostics Inc. to provide telomere flow fluorescence in situ hybridization testing for 45 clinical samples in support of Protocol 17-H-0121. The testing is required to continue patient care, evaluate efficacy and disease progression during the course of drug therapy under the protocol. Repeat Diagnostics will perform the testing at its laboratory located in...
Repeat Diagnostics Inc. has been awarded a firm fixed price purchase order from the National Institutes of Health's National Heart, Lung and Blood Institute (NIH NHLBI) for $31,250. The contract is for specialized flow fluorescence in situ hybridization (flow-FISH) telomere length measurement services to support NHLBI research protocols and patient care through March 2025. Repeat Diagnostics will provide its Flow-FISH 2-Panel assay to measure telomere length using clinical samples, advancing the...
This is a $65,800 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a for-profit limited liability company based in Ottawa, Canada. The contract is for laboratory services to perform telomere length measurement using a 6-panel flow fluorescence in situ hybridization (flow-FISH) assay. This contract supports NCI's research into the correlation between telomere length and...
This is a $16,100.00 firm fixed price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to TRU Diagnostics Inc. The contract is to support research conducted by the Epidemiology and Community Health Branch (ECHB) and the Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LOGICO) within the NHLBI's Division of Intramural Research. The contract provides third-party laboratory services and has an ultimate completion date of September...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $42,427 firm fixed price delivery order contract to Illumina, Inc. to provide reagents and kits necessary for next-generation sequencing on laboratory instruments in support of NHLBI-funded investigators. The place of performance is Illumina's facilities in San Diego, California. The period of performance is one month,...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute (HHS-NIH-NHLBI) awarded a $156,707 purchase order to Illumina, Inc. to renew an existing Illumina service contract. The one-year firm fixed price contract will provide ongoing services in support of the NHLBI's research programs from June 2021 through June 2022. Illumina will perform the work as the prime contractor in San Diego, California. No subcontractors or set aside...